BMS-986156
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-986156, covering 2023-03-06 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers [Phase 1, Phase 2]